Lenacapavir (LEN), a groundbreaking HIV-1 capsid inhibitor developed by Gilead Sciences, stands on the brink of revolutionizing HIV prevention. As...
Lenacapavir (LEN), a groundbreaking HIV-1 capsid inhibitor developed by Gilead Sciences, stands on the brink of revolutionizing HIV prevention. As...